Aortic valve stenosis serum IGFBP2 mediates female-specific Evogliptin resistance in valve myofibroblasts
Cell Reports · 2026-07 · 45 (7) · 117678
DOI: 10.1016/j.celrep.2026.117678 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026-07. Verfasst von Brandon J Vogt und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shu Chien-Gene Lay Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA; Sanford Consortium for Regenerative Medicine…. Hauptthemen laut MEDLINE: Insulin-Like Growth Factor Binding Protein 2, Aortic Valve Stenosis, Myofibroblasts, Drug Resistance. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, The Chan Zuckerberg Initiative, National Heart Lung and Blood Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shu Chien-Gene Lay Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA; Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA.
- Sulpizio Cardiovascular Center, University of California, San Diego, La Jolla, CA, USA.
- Shu Chien-Gene Lay Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA; Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA; Program in Materials Science and Engineering, Uni…
Förderung
- NHLBI NIH HHS
- The Chan Zuckerberg Initiative
- National Heart Lung and Blood Institute
- American Heart Association Inc
- National Science Foundation
Zitieren
APA
Vogt, B. J., Chavez, M., Félix Vélez, N. E., Gorashi, R. M., Reeves, R. R., & Aguado, B. A. (2026). Aortic valve stenosis serum IGFBP2 mediates female-specific Evogliptin resistance in valve myofibroblasts. Cell Reports, 45(7), 117678. https://doi.org/10.1016/j.celrep.2026.117678
Vancouver
Vogt BJ, Chavez M, Félix Vélez NE, Gorashi RM, Reeves RR, Aguado BA. Aortic valve stenosis serum IGFBP2 mediates female-specific Evogliptin resistance in valve myofibroblasts. Cell Reports. 2026;45(7):117678. doi:10.1016/j.celrep.2026.117678
BibTeX
@article{Vogt2026,
author = {Vogt, Brandon J and Chavez, Megan and Félix Vélez, Nicole E and Gorashi, Rayyan M and Reeves, Ryan R and Aguado, Brian A},
title = {Aortic valve stenosis serum IGFBP2 mediates female-specific Evogliptin resistance in valve myofibroblasts},
journal = {Cell Reports},
year = {2026},
volume = {45},
number = {7},
pages = {117678},
doi = {10.1016/j.celrep.2026.117678}
}
EUVIMED